HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, ...
TAMPA, Fla., Jan. 11, 2018 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCQX:HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative ...
TAMPA, Fla., May 29, 2019 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a biopharmaceutical company focused on the discovery, development and commercialization of innovative ...
THE Insurance Commission (IC) on Monday said it placed Himlayang Pilipino Plans Inc. (HPPI) under conservatorship as it was unable to "address its insolvency issues and fill up trust fund deficiencies ...
TAMPA, Fla., May 30, 2017 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCQX:HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative ...
MANILA, Philippines — Pre-need firm Himlayang Pilipino Plans Inc. (HPPI) has been placed under liquidation by the government. In its latest notice, the Insurance Commission said it had placed HPPI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results